Overview
Gregory Rachu is a Palliative Medicine provider practicing medicine in Providence, Rhode Island. He has been practicing medicine for over 18 years.
His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Heart Failure with Preserved Ejection Fraction (HFpEF), and End-Stage Renal Disease (ESRD).
He is actively involved in clinical research, co-authoring 2 peer reviewed articles.
Graduate Year
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
593 Eddy St, Providence, RI 02903
1085 N Main St, Providence, RI 02904
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Women's Hospital, Heart And Vascular Center
Dr. Michael J. Landzberg is the organizing founder and director of the Boston Adult Congenital Heart and Pulmonary Hypertension Group (BACH) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Landzberg received his medical degree from HMS. He completed a residency in internal medicine at Columbia-Presbyterian Medical Center and a fellowship in cardiovascular disease at BWH. Dr. Landzberg is board certified in internal medicine.Dr. Landzberg’s clinical interests include adult congenital heart disease and pulmonary hypertension. The author of more than 140 peer-reviewed publications, Dr. Landzberg’s research focuses on the management of congenital heart disease. Dr. Landzberg is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Congenital Heart Disease (CHD), Tetralogy of Fallot, Eisenmenger Syndrome, Heart Transplant, and Patent Foramen Ovale Repair. Dr. Landzberg is board certified in Internal Medicine. Dr. Landzberg is currently accepting new patients.
Lahey Hospital & Medical Center
Elizabeth Collins is a Palliative Medicine provider practicing medicine in Burlington, Massachusetts. Dr. Collins is highly rated in 1 condition, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer.
Joseph Alessandro
Joseph Alessandro is a Palliative Medicine provider practicing medicine in Danielson, Connecticut. Dr. Alessandro is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Liver Failure, Relapsing Multiple Sclerosis (RMS), Heart Failure with Preserved Ejection Fraction (HFpEF), and Venous Thromboembolism (VTE).
Frequently Asked Questions about Dr. Gregory S. Rachu
How do I make an appointment with Dr. Gregory S. Rachu?
You can book an appointment with Dr. Gregory S. Rachu by calling their office at 414-257-8500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Gregory S. Rachu a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gregory S. Rachu is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Gregory S. Rachu specialize in?
While Dr. Gregory S. Rachu is a Palliative Medicine, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Heart Failure with Preserved Ejection Fraction (HFpEF), and End-Stage Renal Disease (ESRD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Palliative Medicine.
Does Dr. Gregory S. Rachu participate in research or clinical trials?
Yes. Dr. Gregory S. Rachu has published 2 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Gregory S. Rachu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Gregory S. Rachu accept my insurance?
Dr. Gregory S. Rachu accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 414-257-8500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- End-Stage Renal Disease (ESRD)Dr. Rachu isExperienced. Learn about End-Stage Renal Disease (ESRD).
- Heart Failure with Preserved Ejection Fraction (HFpEF)